Multidisciplinary Head and Neck Cancers Symposium (MHNCS) 2024

Multidisciplinary Head and Neck Cancers Symposium (MHNCS) 2024 is organized by American Society for Radiation Oncology (ASTRO), Society for Immunotherapy of Cancer (SITC), American Society of Clinical Oncology (ASCO) and will be held from Feb 29 - Mar 02, 2024 at JW Marriott Phoenix Desert Ridge Resort & Spa, Phoenix, Arizona, United States of America.

Statement of Need:
The management of head and neck cancer (HNC) is rapidly evolving with newer modality of treatment available to patients. These modalities include minimally invasive surgery, newer radiation targeting techniques, novel targeted therapy and immunotherapy. In addition, the re-classification of patients with locoregionally advanced human papilloma (HPV)+ oropharyngeal carcinoma into earlier stage groups has engendered some confusion surrounding treatment planning. Many large clinical trials are maturing to establish new treatments or standard of care in HNC patients. Improving QOL in our patients who are living longer is a critical need. There is a need to review current guidelines for HNC survivorship care and identify areas of unmet need. It is imperative that the medical professionals involved in the care of HNC patients remain current in the expanding knowledge of this cancer. This meeting provides attendees the opportunity to gain exposure to the latest science in HNC. Attendees need to determine when and how the latest science will affect their day-to-day practice, and thus be able to narrow competency gaps across the management of different HNC subtypes and stages. They also need to understand how to reduce disparities in the care of cancer patients.

Program Objectives:
Upon completion of this live activity, attendees should be able to do the following:
• Explain the importance of multidisciplinary care in HNC and how to best apply it for optimal outcomes.
• Describe key advances in systemic therapy, including targeted therapy and immunotherapy in HNC.
• Discuss recent advances in minimally invasive surgery in HNC and when to apply it in treating early and locally advanced disease.
• Illustrate how we can improve disparities in HNC care.
• Determine the importance of interventions in survivorship clinics for long-term side effects.
• Describe key advances in radiation therapy delivery, targeting and differences between various modalities, including novel treatment approaches such as proton and FLASH radiotherapy.
• Discuss complex cases in HNC and how to best utilize current knowledge for decision making.
• Manage toxicities related to the management of HNC.
• Summarize key recent advances in HNC biology.
• Summarize key recent advances in HNC imaging.
• Discuss and implement standard treatment guidelines for various subtypes of HNCs.